Trevi Therapeutics, Inc. (TRVI) — Institutional Holders, Q2 2026
220 institutional investment managers reported a TRVI position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $2.8B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 1 to 100. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
TRVI in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- FMRAdded · +4,524,778 sh+$84.4M
- Woodline PartnersAdded · +3,080,551 sh+$57.5M
- First Light Asset ManagementNew · +2,097,215 sh+$39.1M
- Assenagon Asset Management S.A.New · +1,525,314 sh+$28.4M
- BARCLAYS PLCAdded · +1,088,492 sh+$20.3M
Biggest sellers
- VIKING GLOBAL INVESTORSTrimmed · -1,654,000 sh-$30.8M
- MARSHALL WACE, LLPTrimmed · -1,291,882 sh-$24.1M
- Rubric Capital ManagementTrimmed · -1,207,860 sh-$22.5M
- CITADEL ADVISORSSold out · -1,201,489 sh-$22.4M
- Octagon Capital AdvisorsTrimmed · -1,170,000 sh-$21.8M
TRVI 13F holders ranked 1–100 of 220
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | NEA Management Company#1 · 13,222,228 sh | 13,222,228 | $246.6M | 15.53% | 0.0% |
| 2 | FMR#2 · 12,562,839 sh | 12,562,839 | $234.3M | 0.01% | +56.3% |
| 3 | BlackRock#3 · 11,155,026 sh | 11,155,026 | $208.0M | <0.01% | +8.9% |
| 4 | Frazier Life Sciences Management, L.P.#4 · 9,939,447 sh | 9,939,447 | $185.4M | 4.04% | 0.0% |
| 5 | WELLINGTON MANAGEMENT GROUP LLP#5 · 5,684,592 sh | 5,684,592 | $106.0M | 0.02% | +9.5% |
| 6 | VANGUARD CAPITAL MANAGEMENT#6 · 5,530,675 sh | 5,530,675 | $103.1M | <0.01% | +11.1% |
| 7 | Vivo Capital#7 · 5,094,668 sh | 5,094,668 | $95.0M | 8.68% | 0.0% |
| 8 | Woodline Partners#8 · 4,081,333 sh | 4,081,333 | $76.1M | 0.24% | +307.8% |
| 9 | Vestal Point Capital#9 · 3,100,000 sh | 3,100,000 | $57.8M | 1.35% | +43.1% |
| 10 | MPM BioImpact#10 · 3,073,577 sh | 3,073,577 | $57.3M | 3.50% | -6.8% |
| 11 | FRONTIER CAPITAL MANAGEMENT#11 · 3,070,740 sh | 3,070,740 | $57.3M | 0.53% | +54.0% |
| 12 | STATE STREET#12 · 3,027,315 sh | 3,027,315 | $56.5M | <0.01% | +13.6% |
| 13 | GEODE CAPITAL MANAGEMENT#13 · 2,928,068 sh | 2,928,068 | $54.6M | <0.01% | +5.4% |
| 14 | MARSHALL WACE, LLP#14 · 2,674,137 sh | 2,674,137 | $49.9M | 0.04% | -32.6% |
| 15 | EVENTIDE ASSET MANAGEMENT#15 · 2,660,000 sh | 2,660,000 | $49.6M | 0.66% | +1.4% |
| 16 | Rubric Capital Management#16 · 2,504,513 sh | 2,504,513 | $46.7M | 0.43% | -32.5% |
| 17 | Artia Global Partners#17 · 2,210,852 sh | 2,210,852 | $41.2M | 7.61% | +9.8% |
| 18 | ACORN CAPITAL ADVISORS#18 · 2,144,844 sh | 2,144,844 | $40.0M | 10.92% | 0.0% |
| 19 | First Light Asset Management#19 · 2,097,215 sh | 2,097,215 | $39.1M | 2.38% | New |
| 20 | Pictet Asset Management Holding SA#20 · 2,013,786 sh | 2,013,786 | $37.6M | 0.04% | +18.0% |
| 21 | Logos Global Management#21 · 1,880,000 sh | 1,880,000 | $35.1M | 1.51% | -21.7% |
| 22 | Affinity Asset Advisors#22 · 1,800,172 sh | 1,800,172 | $33.6M | 1.52% | -10.0% |
| 23 | EMERALD ADVISERS#23 · 1,797,611 sh | 1,797,611 | $33.5M | 0.79% | -2.3% |
| 24 | Siren, L.L.C.#24 · 1,786,867 sh | 1,786,867 | $33.3M | 0.67% | 0.0% |
| 25 | Pivotal bioVenture Partners Investment Advisor#25 · 1,742,672 sh | 1,742,672 | $32.5M | 10.56% | +12.2% |
| 26 | RAYMOND JAMES FINANCIAL#26 · 1,610,657 sh | 1,610,657 | $30.0M | <0.01% | -4.6% |
| 27 | VIKING GLOBAL INVESTORS#27 · 1,544,644 sh | 1,544,644 | $28.8M | 0.08% | -51.7% |
| 28 | BANK OF AMERICA#28 · 1,532,889 sh | 1,532,889 | $28.6M | <0.01% | +26.0% |
| 29 | Assenagon Asset Management S.A.#29 · 1,525,314 sh | 1,525,314 | $28.4M | — | New |
| 30 | ALLIANCEBERNSTEIN L.P.#30 · 2,355,453 sh | 2,355,453 | $28.1M | <0.01% | -17.2% |
| 31 | ORBIMED ADVISORS#31 · 1,430,293 sh | 1,430,293 | $26.7M | 0.49% | -41.7% |
| 32 | Jones Hill Capital#32 · 1,339,212 sh | 1,339,212 | $25.0M | 5.31% | +261.8% |
| 33 | NAN FUNG TRINITY (HK) Ltd#33 · 1,213,620 sh | 1,213,620 | $22.6M | 2.23% | +6.2% |
| 34 | EMERALD MUTUAL FUND ADVISERS#34 · 1,210,965 sh | 1,210,965 | $22.6M | 0.79% | -4.1% |
| 35 | GOLDMAN SACHS GROUP#35 · 1,202,520 sh | 1,202,520 | $22.4M | <0.01% | -2.1% |
| 36 | Jupiter Topco#36 · 1,190,973 sh | 1,190,973 | $22.2M | <0.01% | — |
| 37 | Soleus Capital Management, L.P.#37 · 1,179,618 sh | 1,179,618 | $22.0M | 0.76% | -27.2% |
| 38 | VANGUARD PORTFOLIO MANAGEMENT#38 · 1,176,872 sh | 1,176,872 | $21.9M | <0.01% | +21.5% |
| 39 | BARCLAYS PLC#39 · 1,142,077 sh | 1,142,077 | $21.3M | <0.01% | +2031.3% |
| 40 | Saturn V Capital Management#40 · 1,052,043 sh | 1,052,043 | $19.6M | 2.81% | New |
| 41 | FLPUTNAM INVESTMENT MANAGEMENT#41 · 1,038,057 sh | 1,038,057 | $19.4M | 0.23% | -2.4% |
| 42 | NORTHERN#42 · 1,006,038 sh | 1,006,038 | $18.8M | <0.01% | +24.7% |
| 43 | CHARLES SCHWAB INVESTMENT MANAGEMENT#43 · 965,402 sh | 965,402 | $18.0M | <0.01% | +14.9% |
| 44 | Candriam S.C.A.#44 · 966,219 sh | 966,219 | $18.0M | 0.08% | +24.9% |
| 45 | BALYASNY ASSET MANAGEMENT L.P.#45 · 845,087 sh | 845,087 | $15.8M | 0.02% | +78.3% |
| 46 | VANGUARD FIDUCIARY#46 · 841,059 sh | 841,059 | $15.7M | <0.01% | +17.7% |
| 47 | MORGAN STANLEY#47 · 800,465 sh | 800,465 | $14.9M | <0.01% | +9.5% |
| 48 | Nuveen#48 · 765,176 sh | 765,176 | $14.3M | <0.01% | +306.6% |
| 49 | Burkehill Global Management#49 · 725,000 sh | 725,000 | $13.5M | 0.49% | +38.1% |
| 50 | SILVERARC CAPITAL MANAGEMENT#50 · 678,095 sh | 678,095 | $12.6M | 1.31% | +32.7% |
| 51 | AMERIPRISE FINANCIAL#51 · 622,381 sh | 622,381 | $11.6M | <0.01% | +23.3% |
| 52 | SUPERSTRING CAPITAL MANAGEMENT#52 · 524,224 sh | 524,224 | $9.8M | 6.17% | +108.4% |
| 53 | SPHERA FUNDS MANAGEMENT LTD.#53 · 499,029 sh | 499,029 | $9.3M | 1.21% | -13.1% |
| 54 | PEREGRINE CAPITAL MANAGEMENT#54 · 444,310 sh | 444,310 | $8.3M | 0.27% | -16.2% |
| 55 | KVP Capital Advisors#55 · 414,000 sh | 414,000 | $7.7M | 5.67% | 0.0% |
| 56 | Ensign Peak Advisors#56 · 396,173 sh | 396,173 | $7.4M | 0.01% | -14.8% |
| 57 | Octagon Capital Advisors#57 · 315,000 sh | 315,000 | $5.9M | 0.53% | -78.8% |
| 58 | Invesco Ltd.#58 · 311,749 sh | 311,749 | $5.8M | <0.01% | -11.7% |
| 59 | Opaleye Management#59 · 310,000 sh | 310,000 | $5.8M | 0.52% | -10.2% |
| 60 | Bank of New York Mellon#60 · 306,681 sh | 306,681 | $5.7M | <0.01% | +17.9% |
| 61 | D. E. Shaw#61 · 281,996 sh | 281,996 | $5.3M | <0.01% | +55.5% |
| 62 | UBS Group AG#62 · 270,498 sh | 270,498 | $5.0M | <0.01% | -39.4% |
| 63 | Informed Momentum#63 · 264,631 sh | 264,631 | $4.9M | 0.44% | New |
| 64 | FIFTH THIRD BANCORP#64 · 260,644 sh | 260,644 | $4.9M | <0.01% | +103.1% |
| 65 | Rock Springs Capital Management#65 · 260,000 sh | 260,000 | $4.8M | 0.24% | New |
| 66 | Trexquant Investment#66 · 242,537 sh | 242,537 | $4.5M | 0.03% | New |
| 67 | Walleye Capital#67 · 241,987 sh | 241,987 | $4.5M | 0.02% | New |
| 68 | F/m Investments#68 · 234,208 sh | 234,208 | $4.4M | 0.22% | +1.1% |
| 69 | Integral Health Asset Management#69 · 200,000 sh | 200,000 | $3.7M | 0.15% | New |
| 70 | Swiss National Bank#70 · 192,300 sh | 192,300 | $3.6M | <0.01% | +14.3% |
| 71 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME#71 · 183,225 sh | 183,225 | $3.4M | <0.01% | +18.8% |
| 72 | PANAGORA ASSET MANAGEMENT#72 · 182,235 sh | 182,235 | $3.4M | 0.01% | -70.9% |
| 73 | SEVEN GRAND MANAGERS#73 · 150,000 sh | 150,000 | $2.8M | 0.11% | New |
| 74 | RHUMBLINE ADVISERS#74 · 132,463 sh | 132,463 | $2.5M | <0.01% | +21.5% |
| 75 | OF TOLEDO NA#75 · 124,002 sh | 124,002 | $2.3M | — | -5.7% |
| 76 | Harvest Investment Services#76 · 115,104 sh | 115,104 | $2.1M | 0.33% | New |
| 77 | WELLS FARGO & COMPANY#77 · 114,707 sh | 114,707 | $2.1M | <0.01% | +201.4% |
| 78 | DEUTSCHE BANK AG\#78 · 114,487 sh | 114,487 | $2.1M | <0.01% | +35.1% |
| 79 | WINTON GROUP Ltd#79 · 106,852 sh | 106,852 | $2.0M | 0.06% | New |
| 80 | Qube Research & Technologies Ltd#80 · 102,226 sh | 102,226 | $1.9M | <0.01% | New |
| 81 | LMR Partners LLP#81 · 100,000 sh | 100,000 | $1.9M | <0.01% | 0.0% |
| 82 | OPPENHEIMER#82 · 99,771 sh | 99,771 | $1.9M | — | -0.3% |
| 83 | SIMPLEX TRADING#83 · 97,557 sh | 97,557 | $1.8M | <0.01% | +381.1% |
| 84 | VOYA INVESTMENT MANAGEMENT#84 · 93,562 sh | 93,562 | $1.7M | <0.01% | +110.9% |
| 85 | Russell Investments Group, Ltd.#85 · 90,926 sh | 90,926 | $1.7M | <0.01% | +33.5% |
| 86 | WEXFORD CAPITAL#86 · 90,752 sh | 90,752 | $1.7M | 0.22% | 0.0% |
| 87 | Erste Asset Management GmbH#87 · 90,000 sh | 90,000 | $1.7M | 0.01% | 0.0% |
| 88 | PRICE T ROWE ASSOCIATES#88 · 88,057 sh | 88,057 | $1.6M | <0.01% | +36.1% |
| 89 | STATE OF WISCONSIN INVESTMENT BOARD#89 · 82,753 sh | 82,753 | $1.5M | <0.01% | -38.6% |
| 90 | Campbell & Investment Adviser#90 · 81,874 sh | 81,874 | $1.5M | 0.08% | +104.5% |
| 91 | J. Goldman#91 · 80,998 sh | 80,998 | $1.5M | 0.04% | -65.8% |
| 92 | Legal & General Group Plc#92 · 79,220 sh | 79,220 | $1.5M | <0.01% | +24.1% |
| 93 | PFS Partners#93 · 79,000 sh | 79,000 | $1.5M | — | 0.0% |
| 94 | CITIGROUP#94 · 77,474 sh | 77,474 | $1.4M | <0.01% | -22.5% |
| 95 | Schonfeld Strategic Advisors#95 · 75,970 sh | 75,970 | $1.4M | <0.01% | New |
| 96 | Checkpoint Capital L.P.#96 · 75,000 sh | 75,000 | $1.4M | 0.36% | +50.0% |
| 97 | TUDOR INVESTMENT ET AL#97 · 73,978 sh | 73,978 | $1.4M | <0.01% | +14.7% |
| 98 | JPMORGAN CHASE#98 · 73,273 sh | 73,273 | $1.4M | <0.01% | +3.7% |
| 99 | VANGUARD ASSET MANAGEMENT, Ltd#99 · 72,296 sh | 72,296 | $1.3M | <0.01% | +35.8% |
| 100 | SEI INVESTMENTS#100 · 68,484 sh | 68,484 | $1.3M | <0.01% | -12.4% |
Funds that sold out of TRVI in Q2 2026 (20)
Held TRVI at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| CITADEL ADVISORS1,201,489 sh | 1,201,489 | $14.3M |
| MILLENNIUM MANAGEMENT570,971 sh | 570,971 | $6.8M |
| GMT CAPITAL317,700 sh | 317,700 | $3.8M |
| Swiss Life Asset Management Ltd21,428 sh | 21,428 | $3.7M |
| Propel Bio Management223,802 sh | 223,802 | $2.6M |
| Squarepoint Ops103,967 sh | 103,967 | $1.2M |
| ExodusPoint Capital Management79,859 sh | 79,859 | $952.7K |
| Simplify Asset Management65,412 sh | 65,412 | $780.4K |
| TWO SIGMA INVESTMENTS38,415 sh | 38,415 | $458.3K |
| AQR CAPITAL MANAGEMENT28,149 sh | 28,149 | $335.8K |
| GROUP ONE TRADING, L.P.25,930 sh | 25,930 | $309.3K |
| IMC-Chicago24,324 sh | 24,324 | $290.2K |
| DIADEMA PARTNERS21,663 sh | 21,663 | $258.4K |
| DIMENSIONAL FUND ADVISORS16,101 sh | 16,101 | $192.1K |
| Hudson Bay Capital Management11,770 sh | 11,770 | $140.4K |
| SIH Partners, LLLP10,001 sh | 10,001 | $119.3K |
| QUADRANT CAPITAL GROUP1,578 sh | 1,578 | $58.4K |
| Federation des caisses Desjardins du Quebec4,300 sh | 4,300 | $51.3K |
| Versant Capital Management232 sh | 232 | $2.8K |
| TWIN PEAKS WEALTH ADVISORS29 sh | 29 | $346.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.